The integration of AI into digital pathology has the potential to transform cancer diagnostics by enabling scalable, ...
The AI in cancer diagnostics market presents significant opportunities driven by advancements in AI and machine learning ...
An artificial intelligence (AI) deep learning tool that estimates the malignancy risk of lung nodules achieved high cancer detection rates while significantly reducing false-positive results. Results ...
A new UCL-led international trial will assess whether AI can perform as well as expert radiologists at detecting prostate ...
A new study in Science Bulletin presents DVSTP, a deep learning system that integrates pathology images with spatial ...
Man’s best friend may become cancer’s worst enemy.
Physiologically Based Pharmacokinetic Model to Assess the Drug-Drug-Gene Interaction Potential of Belzutifan in Combination With Cyclin-Dependent Kinase 4/6 Inhibitors A total of 14,177 patients were ...
Pediatric oncology is rapidly advancing through precision therapeutics, biomarker-informed trials, and adaptive treatment strategies designed to improve ...
Although cancer treatments are improving fast, prevention has so far been mostly about promoting a healthy lifestyle. But ...
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leader in cancer diagnostics, today announced the launch of the Cancerguard™ test, a new multi-cancer early detection (MCED) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results